PDUFA VI Might Adjust Establishment Fees; FDA Aims For Simplification
This article was originally published in The Tan Sheet
Executive Summary
User fees would need significant restructuring to make up revenue if establishment fees are eliminated, or even just changed, as part of reauthorization. As part of FDA-industry negotiations, several small working groups are expected to be created to deal with specific issues.